The global fluconazole market is expected to reach USD 13.39 Billion in 2028 and register a revenue CAGR of 1.4% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth include increasing prevalence of skin and fungal infections among all age groups, high demand for fluconazole in developing countries, and high geriatric population prone to fungal infections.

Over the recent years, there has been rapid increase in the prevalence of fungal infections across the globe owing to factors such as low immunity, constantly changing climatic conditions, and unhygienic lifestyles. Most fungal infections are non-lethal but can cause inconvenience to people suffering from them. Various fluconazole are used to prevent and treat different fungal infections such as athlete’s foot, candidiasis, ringworm, and jock itch. These drugs are either prescribed or are available over-the-counter in hospitals or retail pharmacies.

Some Key Factors Contributing to the Global Pharma & Healthcare Market Growth

Unprecedented revenue growth of the global pharma & healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health & wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in R&D activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some key highlights of the report:

  • Based on route of administration, the oral segment is expected to register steady revenue CAGR between 2021 and 2028. This can be attributed to increasing prevalence of fungal infections and diseases, availability of many broad-spectrum antifungal oral drugs, high preference for tablets due to easy administration and quick absorption, and increasing production of new formulation drugs. 
  • Based on distribution channel, the hospital pharmacies segment is expected to account for significant revenue share over the forecast period. This can be attributed to factors such as increasing patient visits to hospitals, availability of advanced antifungal creams and lotions in hospital pharmacies, improving healthcare infrastructure, and growing demand for prescription as well as over-the-counter drugs. 
  • The European market is expected to account for steady revenue growth during the forecast period owing to factors such as high prevalence of skin infections and fungal diseases, increasing healthcare spending, presence of well-developed healthcare facilities, and availability of advanced treatments for fungal infections. Other factors such as increasing investments in research and development activities, high focus on developing more effective drugs for fungal diseases and infections, and presence of leading key players are expected to fuel market growth during the forecast period. 
  • The market in Asia Pacific is expected to register a revenue CAGR of 1.9% over the forecast period owing to increasing prevalence of fungal infections, rising awareness about fungal diseases, growing R&D investments, rising healthcare spending, and improving healthcare infrastructure. Other factors such as favorable government initiatives, rising per capita income, and increasing demand for advanced skincare treatments are also expected to play an important role in growth of the Asia Pacific market. 

Top Players in the Global fluconazole Market:

Pfizer, Inc., Novartis AG, Merck & Co., Inc., Sanofi-Aventis, Bayer AG, Enzon Pharmaceuticals, Inc.; GlaxoSmithKline Plc; Astellas Pharma, Inc., Gilead Sciences, Inc., Leadiant Biosciences, Inc., Sigma-Aldrich, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Mylan N.V, Maan Medex Private Ltd., Lifevision Healthcare, and Medico Remedies Limited are some key companies operating in the global fluconazole market.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.  

To know more about the report @ https://www.reportsanddata.com/report-detail/antifungal-drugs-market

fluconazole Market Segmentation:

Drug Class Outlook (Revenue, USD Billion, 2018-2028)

  • Azoles
    • Voriconazole
    • Posaconazole
    • Clotrimazole
    • Isavuconazole
    • Others
  • Echinocandins
    • Caspofungin
    • Micafungin
    • Others
  • Polyenes
    • Amphotericin B
    • Candicidin
    • Hamycin
    • Natamycin
    • Others
  • Allylamines
    • fluconazole
    • Others
  • Others 

Route of Administration Outlook (Revenue, USD Billion, 2018-2028)

  • Oral
  • Topical
  • Parenteral

Indication Outlook (Revenue, USD Billion, 2018-2028)

  • Candidiasis
    • Invasive Candidiasis
    • Vulvovaginal Candidiasis (VVC)
    • Mouth/Throat/Esophageal Candidiasis
    • Others
  • Dermatophytosis
  • Aspergillosis
  • Others

Distribution Channel Outlook (Revenue, USD Billion, 2018-2028)

  • Hospitals Pharmacies
  • Specialty Clinics
  • Retail Pharmacies
  • Online Pharmacies

Global fluconazole Market Report: Regional Segmentation

  • North America
    • S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • A.E.
    • South Africa
    • Rest of MEA

Global fluconazole Market: Table of Contents

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

       1.4.1. Primary Sources

       1.4.2. Secondary Sources

       1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

Chapter 3. Key Insights

Chapter 4. Global Pharma & Healthcare Market Segmentation 

4.1. Global Pharma & Healthcare Market COVID-19 Impact Analysis

4.2. Industrial Outlook

       4.2.1. Market indicators analysis

       4.2.2. Market drivers’ analysis

       4.2.3. Market restraints analysis

 4.3. Technological Insights

 4.4. Porter’s Five Forces Analysis

 4.5. Regulatory Framework

 4.6. Price trend Analysis

 4.7. Competitive Metric Space Analysis

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1399

Read More Reports:

Bioresorbable Coronary Stents Market @ https://www.reportsanddata.com/report-detail/bioresorbable-coronary-stents-market

Electrophysiology (EP) Catheter Market @ https://www.reportsanddata.com/report-detail/electrophysiology-catheter-market

Nerve Monitoring Devices Market @ https://www.reportsanddata.com/report-detail/nerve-monitoring-devices-market

Hospital Acquired Infection Treatment Market @ https://www.reportsanddata.com/report-detail/hospital-acquired-infection-treatment-market

Frequently Asked Questions Answered in the Report:

  • What is the estimated revenue growth rate of the global fluconazole market over the forecast period?
  • What are the major factors driving the global market revenue growth?
  • Which are the leading manufacturers and suppliers in the global fluconazole market?
  • Which regional market is expected to lead in terms of revenue share in the global fluconazole market over the forecast years?
  • What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.